[Disease burden of prostate cancer among men in China, from 1990 to 2013].

To analyze the disease burden of prostate cancer among men in China in 1990 and 2013.

Based on the estimation of data in China from the Global Burden of Disease 2013 (GBD2013), incidence, mortality, the years of life lost due to disability-adjusted life years (DALY), years of life lost due to premature mortality (YLL), and years lived with disability (YLD) on prostate cancer for men in China in 1990 and 2013, were standardized by the world standard population used for GBD2013. Incidence, mortality and the disease burden due to prostate cancer in China were analyzed.

The numbers on incidence, deaths, standardized incidence and mortality rates on prostate cancer increased rapidly in 2013 were compared with the data in 1990. New cases increased by 490.27%, from 13 800 in 1990 to 81 400 in 2013 while number of deaths increased by 206.86%, from 5 800 to 17 800 and the standardized incidence rate increased by 197.54%, from 4.48/100 000 to 13.33/100 000. The standardized mortality rate increased by 46.9%, from 2.26/100 000 to 3.32/100 000. The proportion of deaths due to prostate cancer among all the cancers of men also increased, from 0.65% to 1.26%. Both incidence and death rates increased with age, with the lowest in 0-49 years old and highest in over 80 years old groups. In 1990 and 2013, the incidence and mortality rates of prostate cancer increased in all the age groups, with the highest in 65-69 years old (228.65%). The disease burden on prostate cancer in 2013, compared with the data in 1990 with DALY, YLL and YLD increased by 30.66, 25.51 and 5.15 ten thousand person years, respectively, from 1990 to 2013, with the rates of annual increase as 1.05%, 1.04% and 1.07%, respectively. The age-standardized rate of DALY, YLL and YLD increased in 2013, compared with the data in 1990 with the increasing rate as 1.02%, 1.01% and 1.04%, respectively. The proportion of disease burden due to prostate cancer among all the male cancers showed an increase. The proportion of DALY and YLL increased by 1.03% and 1.04%, respectively. DALY, YLL, YLD and their corresponding rates all increased with age, with the lowest seen in the 0-49 year old group and highest in 70-79 year old group but with slight decline in the group older than 80 years of age.

Both the incidence and mortality of prostate cancer showed significant increase in China. Prevention and control programs on prostate cancer should be strengthened.

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2016 Jun 10 [Epub]

J L Qi, L J Wang, M G Zhou, Y N Liu, J M Liu, S W Liu, X Y Zeng, P Yin

Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Division of Integrated Prevention and Evaluation, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Division of Integrated Prevention and Evaluation, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.